| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |